Fish oil supplementation in chronic obstructive pulmonary disease: feasibility of conducting a randomised controlled trial
Abstract Background Long-chain omega-3 polyunsaturated fatty acids (LCn-3PUFAs) may act as an effective adjunct therapy for chronic obstructive pulmonary disease (COPD), a condition characterised by persistent airflow limitation and inflammation. However, the nature of this illness presents challeng...
Main Authors: | Ashley S. Fulton, Alison M. Coates, Marie T Williams, Peter R. C. Howe, Manohar L. Garg, Lisa G. Wood, Peter Frith, Alison M. Hill |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Pilot and Feasibility Studies |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40814-017-0211-2 |
Similar Items
-
Persistent Citation of the Only Published Randomised Controlled Trial of Omega-3 Supplementation in Chronic Obstructive Pulmonary Disease Six Years after Its Retraction
by: Ashley S. Fulton, et al.
Published: (2015-02-01) -
Feasibility of a randomised controlled trial of fish oil supplementation in people with chronic obstructive pulmonary disease
by: A.S. Fulton, et al.
Published: (2016-06-01) -
The most frequent comorbidities at patients with the chronic obstructive pulmonary disease
by: Krdžić Biljana, et al.
Published: (2018-01-01) -
Expanding The INSPIRED COPD Outreach ProgramTM to the emergency department: a feasibility assessment
by: Gillis D, et al.
Published: (2017-05-01) -
Chronic airflow obstruction in Tanzania – a cross-sectional study
by: Thomas Zoller, et al.
Published: (2018-01-01)